Latest Nanotechnology News RSS Feed - Nanotechnology News

Global Industry Analysis Report on Nanosilver Market

Global Industry Analysis Report on Nanosilver Market

Research and Markets has announced the addition of the "Nanosilver Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. [More]
Major Aviation Component Supplier Places $1.7 Million Order with CVD Equipment

Major Aviation Component Supplier Places $1.7 Million Order with CVD Equipment

CVD Equipment Corporation announced today that it has received a $1.7 million order for additional features to be incorporated into the multi-million dollar order we received earlier this year from a major aviation component supplier. [More]
Glasgow Nanofabrication Expert Honored with Institute of Physics President’s Medal

Glasgow Nanofabrication Expert Honored with Institute of Physics President’s Medal

Professor Douglas Paul received the Institute of Physics President’s Medal at an event in London today (Wednesday 15 October). [More]
Oxford Instruments Plasma Technology and IOP to Hold Webinar on Fabrication Technologies for 2D Materials

Oxford Instruments Plasma Technology and IOP to Hold Webinar on Fabrication Technologies for 2D Materials

One of the key technical challenges when working towards the commercial realisation of graphene and related 2D materials is the development of robust fabrication techniques for deposition, etching and integration with other processes in a device-fabrication facility. [More]
French ANSM Grants Approval for Nanobiotix’s NBTXR3 Phase II/III Registration Trial for Soft Tissue Sarcoma

French ANSM Grants Approval for Nanobiotix’s NBTXR3 Phase II/III Registration Trial for Soft Tissue Sarcoma

NANOBIOTIX, a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announced today that it has received approval from the French National Security Agency for Medicines and Health Products (ANSM) to start its Phase II/III registration trial of its lead product, NBTXR3, in patients with locally advanced Soft Tissue Sarcoma (STS). [More]
Global Graphene Market Forecast to Grow at 44.0% CAGR to Reach $149.1 Million by 2020

Global Graphene Market Forecast to Grow at 44.0% CAGR to Reach $149.1 Million by 2020

Research and Markets has announced the addition of the "Global Graphene Market (Product Type, Application, Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020" report to their offering. [More]
Undergraduate Delves into Nanotechnology Research at UC’s Nanoworld Lab

Undergraduate Delves into Nanotechnology Research at UC’s Nanoworld Lab

A summer of research certainly paid off for Christian Lipa, a sophomore in mechanical engineering, who decided to take a step outside his comfort zone and delve into the world of nanotechnology (the study of tiny particles) in the University of Cincinnati Nanoworld Lab. [More]
Niels Bohr Institute Professor Honored with Prize for 'Research Excellence in Nanotechnology'

Niels Bohr Institute Professor Honored with Prize for 'Research Excellence in Nanotechnology'

Charles Marcus, who is a professor and head of the Center for Quantum Devices at the Niels Bohr Institute at the University of Copenhagen, has been awarded the prize for 'Research Excellence in Nanotechnology' by the nanoscience centre, NBIC at the University of Pennsylvania, USA. It is an international prize and is given in recognition of outstanding research in nanotechnology. [More]
Selecta, JDRF add Sanofi in Partnership to Develop Synthetic Vaccine Particle Immunotherapy for Diabetes

Selecta, JDRF add Sanofi in Partnership to Develop Synthetic Vaccine Particle Immunotherapy for Diabetes

Selecta Biosciences, Inc., and JDRF, announced today that they have extended their joint research collaboration and attracted Sanofi as a partner in support of their program to develop a Synthetic Vaccine Particle (SVP™) immunotherapy with the long-term goal to treat and potentially prevent the underlying cause of type 1 diabetes. [More]
Novavax’s RSV F-Protein Nanoparticle Vaccine Candidate Evokes Polyclonal Antibody Response to Antigenic Site II

Novavax’s RSV F-Protein Nanoparticle Vaccine Candidate Evokes Polyclonal Antibody Response to Antigenic Site II

Novavax, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that its RSV F-protein nanoparticle vaccine candidate (RSV F Vaccine) evoked a polyclonal antibody response to antigenic site II, the same site targeted by the monoclonal antibody palivizumab (Synagis®), resulting in protection from an RSV challenge in an animal model. [More]
GMZ Energy Introduces Hafnium-Free P-type Half-Heusler Material

GMZ Energy Introduces Hafnium-Free P-type Half-Heusler Material

GMZ Energy, a leading provider of nano-structured high-temperature thermoelectric generation (“TEG”) power solutions, today announced its new Hafnium-free p-type half-Heusler material, which has substantially lower raw material cost than conventional half-Heusler materials. The material also features dramatically enhanced performance and mechanical strength due to GMZ’s patented nanostructuring process. [More]
Major Advance in Implementation of ETPN Nanomedicine Translation Hub

Major Advance in Implementation of ETPN Nanomedicine Translation Hub

A major step in implementing the ETPN Translation Hub has been reached, with three European projects entering the finalisation stage of their EU Grant Agreements. The project ENATRANS is for networking of SMEs in the nano-biomedical sector and supporting the SMEs with getting their products from the laboratory phase to the clinical applications. [More]
Scientists Pinpoint Crucial Steps in DNA Replication

Scientists Pinpoint Crucial Steps in DNA Replication

The proteins that drive DNA replication—the force behind cellular growth and reproduction—are some of the most complex machines on Earth. The multistep replication process involves hundreds of atomic-scale moving parts that rapidly interact and transform. Mapping that dense molecular machinery is one of the most promising and challenging frontiers in medicine and biology. [More]
Anticancer Nanomedicines Have an Optimal Particle Size

Anticancer Nanomedicines Have an Optimal Particle Size

Nanomedicines consisting of nanoparticles for targeted drug delivery to specific tissues and cells offer new solutions for cancer diagnosis and therapy. Understanding the interdependency of physiochemical properties of nanomedicines, in correlation to their biological responses and functions, is crucial for their further development of as cancer-fighters. [More]
US Branch Opened by Graphenea

US Branch Opened by Graphenea

Graphenea has opened a branch in the USA to assist more immediate service of the company's North American customers. The US branch, Graphenea Inc, is based in Cambridge (Boston), MA, due to the close relation that... [More]

News Categories